Nucleus accumbens activation is linked to salience in social decision making

被引:13
|
作者
Schmidt, Stephanie N. L. [1 ,2 ]
Fenske, Sabrina C. [1 ]
Kirsch, Peter [1 ]
Mier, Daniela [1 ,2 ]
机构
[1] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Clin Psychol, J5, D-68159 Mannheim, Germany
[2] Univ Konstanz, Dept Psychol, Constance, Germany
关键词
Emotion recognition; Decision making; Jumping-to-conclusion bias; Aberrant salience; Schizophrenia; Nucleus accumbens; ANTERIOR CINGULATE CORTEX; BRAIN REWARD SYSTEM; EMOTION RECOGNITION; PREFRONTAL CORTEX; FUNCTIONAL NEUROANATOMY; REDUCED-ACTIVATION; FACIAL EXPRESSIONS; AMYGDALA RESPONSE; VENTRAL STRIATUM; LINKING BIOLOGY;
D O I
10.1007/s00406-018-0947-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aberrant salience may explain hasty decision making and psychotic symptoms in schizophrenia. In healthy individuals, final decisions in probabilistic reasoning tasks are related to Nucleus accumbens (Nacc) activation. However, research investigating the Nacc in social decision making is missing. Our study aimed at investigating the role of the Nacc for social decision making and its link to (aberrant) salience attribution. 47 healthy individuals completed a novel social jumping-to-conclusion (JTC) fMRI-paradigm, showing morphed faces simultaneously expressing fear and happiness. Participants decided on the 'current' emotion after each picture, and on the 'general' emotion of series of faces. Nacc activation was stronger during final decisions than in previous trials without a decision, particularly in fear rather than happiness series. A JTC-bias was associated with higher Nacc activation for last fearful, but not last happy faces. Apparently, mechanisms underlying probabilistic reasoning are also relevant for social decision making. The pattern of Nacc activation suggests salience, not reward, drives the final decision. Based on these findings, we hypothesize that aberrant salience might also explain social-cognitive deficits in schizophrenia.
引用
收藏
页码:701 / 712
页数:12
相关论文
共 50 条
  • [1] Nucleus accumbens activation is linked to salience in social decision making
    Stephanie N. L. Schmidt
    Sabrina C. Fenske
    Peter Kirsch
    Daniela Mier
    European Archives of Psychiatry and Clinical Neuroscience, 2019, 269 : 701 - 712
  • [2] Valence and salience contribute to nucleus accumbens activation
    Cooper, Jeffrey C.
    Knutson, Brian
    NEUROIMAGE, 2008, 39 (01) : 538 - 547
  • [3] The influence of insight on risky decision making and nucleus accumbens activation
    Becker, Maxi
    Yu, Yuhua
    Cabeza, Roberto
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [4] The influence of insight on risky decision making and nucleus accumbens activation
    Maxi Becker
    Yuhua Yu
    Roberto Cabeza
    Scientific Reports, 13 (1)
  • [5] Selective activation of the nucleus accumbens during risk-taking decision making
    Matthews, SC
    Simmons, AN
    Lane, SD
    Paulus, MP
    NEUROREPORT, 2004, 15 (13) : 2123 - 2127
  • [6] Activation of cannabinoid system in nucleus accumbens affects cost-benefit decision making
    Vanani, Z. Fatahi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S279 - S280
  • [7] Activity in the nucleus accumbens explains individual differences in rapid and intuitive social decision making
    Haruno, Masahiko
    Frith, Chris
    Kimura, Minoru
    NEUROSCIENCE RESEARCH, 2011, 71 : E104 - E104
  • [8] Representations of Distinct Salience Signals in the Nucleus Accumbens
    Murty, Vishnu P.
    Stanek, Jessica K.
    Heusser, Andrew C.
    JOURNAL OF NEUROSCIENCE, 2013, 33 (39): : 15319 - 15320
  • [9] Neuropeptide Y and representation of salience in human nucleus accumbens
    Katherine G. Warthen
    Benjamin Sanford
    Kendal Walker
    Keith G. Jones
    Mike Angstadt
    Chandra Sripada
    David Goldman
    Jon-Kar Zubieta
    Robert C. Welsh
    Margit Burmeister
    Brian J. Mickey
    Neuropsychopharmacology, 2019, 44 : 495 - 502
  • [10] Neuropeptide Y and representation of salience in human nucleus accumbens
    Warthen, Katherine G.
    Sanford, Benjamin
    Walker, Kendal
    Jones, Keith G.
    Angstadt, Mike
    Sripada, Chandra
    Goldman, David
    Zubieta, Jon-Kar
    Welsh, Robert C.
    Burmeister, Margit
    Mickey, Brian J.
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (03) : 495 - 502